List is sorted by tweets
Rating (?)
Tweets (*)
pr *
  • Shire Pharmaceuticals Group plc
  • www.shire.com
  • Global specialty pharmaceutical company focusing on central nervous system (CNS), gastrointestinal (GI), and renal diseases. Based in Chineham, England. (Nasdaq: SHPGY)
4.2
(si*)
>10
6
  • Gilead Sciences, Inc.
  • www.gilead.com
  • A biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for viral diseases, infectious diseases and cancer. It has research, development and manufacturing facilities in the U.S., and marketing organizations in Europe and Australia.
4.4
(si*)
>10
7
  • Oculus Innovative Sciences
  • www.oculusis.com
  • Developer of Microcyn 60 disinfectant, L3 oncology compound and drug-eluting stents along with other disruptive health care technologies.
3.6
(si*)
<10
3
  • Vernalis
  • www.vernalis.com
  • Biopharmaceutical research and development of treatments for migraine, obesity, sexual disfunction and Parkinson disease.
3.6
(si*)
<10
5
  • Valeant Pharmaceuticals International
  • www.valeant.com
  • Development and marketing of medications used in the fields of neurology, dermatology and infectious diseases. Includes corporate and production details. Headquarters in Aliso Viejo, California, USA.
3.4
(si*)
<5
0
  • Access Pharmaceuticals
  • www.accesspharma.com
  • A broadly based emerging pharmaceutical company, with a balanced technology pipeline of novel low development risk product candidates and longer-term major product opportunities.
3.6
(si*)
<5
3
  • Eisai Inc.
  • www.eisai.com
  • A research based human healthcare company that discovers, develops and markets medical products in onoclogy, neurology and gastrointestinal.
3.7
(si*)
<5
6
  • ThromboGenics Ltd
  • www.thrombogenics.com
  • A company focused on discovery and development of biotherapeutics for treatment of vascular diseases.
3.9
(si*)
<5
6
3.6
(si*)
<5
4
  • Novogen Ltd.
  • www.novogen.com
  • Discovers, develops, manufactures and markets isoflavonoids for menopausal non-prescription drugs, and multiple signal transduction regulator drugs for cancer. Includes technological overview, and history of company, with offices in Europe and North America, and headquarters in North Ryde, New South Wales. (Nasdaq: NVGN)
3.8
(si*)
<5
4
Also see: